Answers are grounded in this paper and cite their sources.
. Metabolomic analysis demonstrated widespread degradation of membrane glycerophospholipids and alterations in the arachidonic acid-prostaglandin inflammatory axis, as evidenced by substrate consumption and accumulation of the pro-inflammatory mediator 20-hydroxy-PGE2. We propose a hypothetical working model in which PDCoV infection is associated with PPAR network modulation, potentially contributing to lipid resource reallocation and the establishment of a pro-inflammatory microenvironment that may exacerbate intestinal injury. Notably, similarities can be observed between these PDCoV-associated alterations and the metabolic-immune dysregulation reported in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, raising the hypothesis of shared pathogenic features across coronaviruses. Our findings highlight the PPAR pathway and its downstream lipid mediators as potential therapeutic targets warranting further investigation, and suggest that existing PPAR agonists may merit evaluation as candidate drugs for repurposing in future studies.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: